Skip to search formSkip to main contentSkip to account menu

NCQ 436

Known as: Benzamide, 3-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-5,6-dihydroxy-2-methoxy-, (S)-, NCQ-436 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Remoxipride
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)